指南与共识妇产影像泌尿生殖MR

更新版ESUR子宫内膜癌指南:将MRI与2023 FIGO分期变革相结合

Updated ESUR Guidelines for Endometrial Cancer: integrating MRI with the 2023 FIGO Staging Revolution.
指南 / 共识 · Eur Radiol · 2025-06-30

本文总结2023年FIGO子宫内膜癌分类的关键更新(纳入分子分型),并分析修订版ESUR MRI推荐与新FIGO框架的衔接,重点在于评估肌层浸润和宫颈间质受累。更新版ESUR推荐强调标准化MRI方案,尤其是多期增强成像,以提高肌层浸润诊断信心并支持分期与手术规划。

要点

  • 2023 FIGO子宫内膜癌分期纳入分子分型,MRI需相应调整以准确评估病变范围。
  • 更新版ESUR推荐强调多期增强MRI、结构化报告并与FIGO 2023分类整合。
  • 标准化MRI方案可提高分期准确性、减少诊断差异并指导手术与治疗策略。

核心结论

  • 将分子分类整合进FIGO分期,并以ESUR推荐的标准化和先进MRI方案为支撑,可改善子宫内膜癌的管理。

研究设计与样本

  • 综述:回顾更新版2023 FIGO分类(整合分子分型与组织病理学标准),并分析修订版ESUR MRI推荐与新FIGO框架的衔接。

诊断标准与关键数值

  • 更新版ESUR推荐强调标准化MRI方案,尤其使用多期增强成像,以提高评估肌层浸润的诊断信心。
  • 更新版ESUR推荐强调结构化报告并与FIGO 2023分类整合,以提升分期和治疗规划的诊断精确性。

临床应用与阅片要点

  • MRI在区分分期、描绘病变范围和指导手术规划中持续发挥关键作用。
  • 更新版ESUR推荐强调多期增强成像用于评估肌层浸润,以提高诊断信心。
  • 标准化MRI方案与FIGO 2023系统对齐,可改善分期、指导手术与治疗策略、减少诊断差异。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To summarize the key updates introduced in the 2023 International Federation of Gynecology and Obstetrics (FIGO) classification for endometrial cancer (EC), and to highlight the role of MRI in aligning with these changes for improved staging and patient management.

MATERIALS AND METHODS: A review of the updated 2023 FIGO classification, which integrates molecular profiling and histopathological criteria, was conducted. Additionally, the revised European Society of Urogenital Radiology (ESUR) MRI recommendations were analyzed to assess their alignment with the new FIGO framework, focusing on their role in evaluating myometrial invasion (MI) and cervical stromal involvement.

RESULTS: The updated FIGO classification incorporates molecular data to refine risk stratification and staging accuracy. MRI continues to play a pivotal role in distinguishing between stages, mapping disease extent, and guiding surgical planning. The updated ESUR recommendations emphasize standardized MRI protocols, particularly the use of multiphase contrast-enhanced imaging, to improve diagnostic confidence in assessing MI.

CONCLUSION: The integration of molecular classification into FIGO staging, supported by standardized and advanced MRI protocols as recommended by ESUR, enhances the management of endometrial cancer.

KEY POINTS: Question The 2023 FIGO update integrates molecular profiling into endometrial cancer staging, requiring MRI adaptations to improve accuracy in assessing disease extent, including myometrial invasion. Findings Updated ESUR MRI guidelines emphasize multiphase contrast-enhanced imaging, structured reporting, and integration with FIGO 2023 classification, enhancing diagnostic precision for staging and treatment planning. Clinical relevance Standardized MRI protocols aligned with FIGO 2023 system improve endometrial cancer staging, guiding optimal surgical and therapeutic strategies, reducing diagnostic variability, and enhancing patient outcomes through individualized risk stratification and personalized treatment.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Nougaret S, Sala E, Lakhman Y, et al. Updated ESUR Guidelines for Endometrial Cancer: integrating MRI with the 2023 FIGO Staging Revolution. Eur Radiol. 2025. PMID: 40586816. doi:10.1007/s00330-025-11700-3

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。